carisoprodol package insert rating
4-5 stars based on
Carisoprodol has been subject to abuse, misuse, and criminal diversion for nontherapeutic use [see Warnings and Precautions (5.2)]. 9.2 Abuse. Abuse of carisoprodol poses a risk of overdosage which may lead to death, CNS and respiratory depression, hypotension, seizures and other disorders [see Warnings and Precautions (5.2) and Overdosage (10)].
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information ... The primary metabolite of carisoprodol, meprobamate, ...
Vensun Pharmaceuticals, Inc.: Carisoprodol tablets USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in...
Carisoprodol, the active ingredient in carisoprodol tablets, has been subject to abuse, dependence, withdrawal, ... Package Description Marketing Start Date
carisoprodol package insert - klapprodtpools.com
SOMA [package insert]. Somerset, NJ: Meda Pharmaceuticals Inc.; 2007 2. Data on file. Meda Pharmaceuticals Inc. Indication: SOMA (carisoprodol) is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.
Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Soma (carisoprodol)
Jubilant Cadista Pharmaceuticals Inc.: Carisoprodol tablets USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal...
In the post marketing experience with CARISOPRODOL, cases of dependence, withdrawal, and abuse have been reported with prolonged use. Most cases of dependence, withdrawal, and abuse occurred in patients who have had a history of addiction or who used CARISOPRODOL in combination with other drugs with abuse potential.
Carisoprodol official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.